Gennex Laboratories Ltd Share Price Today - Gennex Laboratories Ltd Stock Price Live NSE/BSE

Gennex Laboratories Ltd

NSE: BSE: 531739

₹9.94

(-1.00%)

Wed, 20 May 2026, 03:24 am

MTF 5xInvest in Gennex Laboratories Ltd with 5x Leverage Buy with MTF

Market Cap2.27B

PE Ratio13.41

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Gennex Laboratories Share Price Live Chart

1 Day

(-1.00%)

No Result Found

Summary

Market Cap
266.03
Net Profit
18.12
P/B
1.51
Sector P/E
34.63
P/E
15.06
EV/EBITDA
8.47
Debt/Equity (Industry)
0.17
Interest Cover (Industry)
18.19
ROCE (Industry)
20.67
RONW (Industry)
17.71
ROE
10.15
ROCE
12.40
Debt/Equity
0.04
EPS (TTM)
0.72
Dividend Yield
0
Book Value
8.79
Interest Cover
6.93

Analysis

all

Pros

Gennex Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Gennex Laboratories is profitable, therefore cash runway is not a concern.
Gennex Laboratories is profitable, therefore cash runway is not a concern.
Debt is well covered by operating cash flow (41.8%, greater than 20% of total debt).
Debt is covered by short term assets, assets are 7.2x debt.

Cons

Unable to evaluate Gennex Laboratories's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Gennex Laboratories's dividend against the top 25% market benchmark as the company has not reported any payouts.
High level of physical assets or inventory.
Gennex Laboratories is not covered by any analysts.
Gennex Laboratories has significant price volatility in the past 3 months.

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	23.63	23.62	23.62	19.83	18.42
FII	0	0	0	0	0
DII	0.00	0.00	0.00	0.00	0.00
Public	76.37	76.38	76.38	80.17	81.58
Government	0	0	0	0	0

Technical Analysis

RSI

62.11

MACD

-0.04

50 DMA

9.81

200 DMA

12.20

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	16.67	13.07	11.53	9.47	7.93	5.87	2.27
Fibonacci	13.07	11.69	10.84	9.47	8.09	7.24	5.87
Camarilla	10.99	10.66	10.33	9.47	9.67	9.34	9.01

Pivots Level: Classic

+7.20

16.67

+3.60

13.07

+2.07

11.53

9.47

Pivot Point

LTP: 10.95

-1.53

7.93

-3.60

5.87

-7.20

2.27

Moving Average

SMAEMA

Period

Value

10-EMA
9.94
20-EMA
9.96
30-EMA
10.01
50-EMA
10.24
100-EMA
10.96
200-EMA
11.94

Announcement Date	Purpose	Action	Ex Date
16 Apr 2026	egm
14 Feb 2026	board-meetings	Quarterly Results
14 Nov 2025	board-meetings	Quarterly Results, Half Yearly Results
04 Sept 2025	agm
06 Sept 2024	agm
04 Dec 2023	egm
09 Sept 2023	agm
06 Sept 2022	agm
18 Jul 2022	rights	1:2 Rights Issue of Equity Shares	22 Jul 2022
22 Jun 2022	rights	Right Issue of Equity Shares	22 Jul 2022

Gennex Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd

Cipla Ltd

Divis Laboratories Ltd

Gennex Laboratories Ltd About

Gennex Laboratories is engaged in the business of manufacturing of Bulk Drugs and Intermediaries.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1990

Headquarters

CEO

Arihant Baid

Employees

Contact

Website

http://www.gennexlab.com

investorrelations@gennexlab.com

Phone

91-8458-279406/279516

Location

Survey No 133 Bollaram, Jinnaram Mandal, Medak, Telangana, 502325

Year	History
1994	The company was converted to a Public Limited Company by a resolution passed by its members at the Extraordinary General Body Meeting held on 3rd November. Mr. Vinod Baid and his associates acquired the entire holding of Pharmasia Limited in November.
1995	A fresh certificate of incorporation consequent upon the change of name of the company was issued by the Registrar of Companies, Andhra Pradesh, on 22nd February. A fresh certificate of incorporation consequent upon the conversion of the company was issued by the Registrar of Companies, Andhra Pradesh, on 15th February. The trial production was completed in September.
2007	The company name was changed from Prudential Pharmaceuticals Ltd to Gennex Laboratories Ltd.
2009	The company split its face value of shares from Rs 10 to Re 1.
2022	The company issued rights shares of Rs. 1 in the ratio of 1:2 at a premium of Rs. 5 per share.

Client Name	Deal Type	Order Side	QTY	Avg Price	Date
ANUPRIYA CONSULTANTS PVT LTD	bulk	Buy	1934782	9.97	19 May 2026
DORITE TRACON PRIVATE LIMITED	bulk	Buy	1501719	13.75	15 Oct 2025
KAMAL KUMAR DUGAR AND CO ( PROP : KAMAL KUMAR DUGAR)	bulk	Sell	1175000	13.81	15 Oct 2025
NARANTAK DEALCOMM LIMITED	bulk	Buy	2000000	13.37	14 Oct 2025
TROPICAL AGRO SYSTEM INDIA PRIVATE LIMITED	bulk	Sell	1700000	11.01	30 Sept 2025
MARYADA B	bulk	Buy	1207467	12.73	12 Mar 2025
KAMAL KUMAR DUGAR AND CO ( PROP : KAMAL KUMAR DUGAR)	bulk	Sell	1174666	22.62	18 Oct 2024
L7 HITECH PRIVATE LIMITED	bulk	Sell	2452005	22.87	10 Oct 2024
HEMANT KUMAR JAIN	bulk	Sell	4000000	20.64	07 Oct 2024
MANOJ KUMAR DUGAR (HUF)	bulk	Sell	2500000	20.66	07 Oct 2024

Gennex Laboratories Ltd News

Gennex Labs EGM Voting Results: Resolution Passed

Gennex Laboratories' eEGM on May 12, 2026 saw all resolutions approved with 99.9997% votes in favour. 31,176,049 votes were cast for regularizing Ms. Khushbu Kachhawa as Independent Director.

13 May 2026

companies

Gennex Laboratories Holds EGM on May 12, 2026

Gennex Laboratories conducted an electronic EGM on May 12, 2026, via VC/OAVM, transacting special business to regularize an Additional Director.

12 May 2026

companies

Gennex Labs Sends EGM Notice for Director Regularization

Gennex Laboratories formally sent EGM notice to stock exchanges for May 12, 2026 meeting to regularize Ms. Khushbu Kachhawa as Independent Woman Director, with e-voting from May 08-11, 2026.

20 Apr 2026

companies

Gennex Labs Board Approves EGM for Director Regularization

Gennex Laboratories Limited's board approved convening an EGM on May 12, 2026, to regularize Ms. Khushbu Kachhawa as Non-Executive Independent Woman Director, with e-voting scheduled from May 09-11, 2026.

16 Apr 2026

companies

Gennex Labs Files Q4FY26 SEBI Compliance Certificate

Gennex Laboratories Limited submitted its quarterly certificate under SEBI Regulation 74(5) for dematerialisation compliance for the quarter ended March 31, 2026, through registrar R&D Infotech.

13 Apr 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800